Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Europe's STOXX 600 marks third month of gains on earnings, recovery hopes

Fri, 30th Apr 2021 09:54

* AstraZeneca boosts UK's FTSE 100

* Barclays tumbles despite profit beat

* STOXX 600 chalks up 1.8% rise in April

* European economy dips into second technical recession in
Q1
(Updates to market close)

By Sruthi Shankar and Ambar Warrick

April 30 (Reuters) - European stocks ended lower on Friday
after dismal GDP data, but marked a third straight month of
gains on strong corporate earnings and optimism about an
economic recovery from the COVID-19 pandemic.

The pan-regional STOXX 600 index fell 0.3%,
hovering below its all-time high, and ending the month 1.8%
higher.

Data showed the euro zone economy dipped into a second
technical recession after a smaller than expected contraction in
the first quarter, but is now set for recovery as pandemic curbs
are lifted amid accelerating vaccination campaigns.

The German economy contracted by a greater-than-expected
1.7%, hit by renewed lockdowns, while the French economy grew
more than expected.

But strong earnings showed companies in the euro zone were
well on their way to recover from the impact of the pandemic.

AstraZeneca jumped 4.3% as the British drugmaker
posted better-than-expected results and forecast second half
growth.

Swedish Match rose 0.7% after the tobacco group
reported a much higher first-quarter operating profit than
expected, helped by growth in its Smokefree product segment. UK
peers British American Tobacco and Imperial Brands
rose more than 2% each.

Broadly, European earnings have come in much stronger than
expected, with a higher than usual 71% of companies beating
profit expectations in the first quarter, according to Refinitiv
IBES data. A third of STOXX 600 companies have published results
so far.

"Expectations are high, companies are beating even these
elevated expectations, and yet the market is responding with
caution," Lewis Grant, portfolio manager at Federated Hermes,
wrote in a note.

"At current valuations, and with much pandemic related
uncertainty remaining, many investors are more concerned about
downside than upside."

Strong earnings from British firms helped the European
retailers sector outpace its peers in April with a 6.7%
bounce, while automobile stocks lagged as a global
semiconductor shortage hurt production.

Banking stocks came under pressure on Friday as euro
zone bond yields eased from their highest level since January
2020. But the sector raced past its peers this week with a near
6% gain, driven by a swathe of strong earnings.

Barclays tumbled 7% despite reporting a quarterly
profit that more than doubled, while France's BNP Paribas
slipped 0.8% on higher costs.

Spain's Banco Sabadell jumped 8.7% to the top of
the STOXX 600 after its quarterly profit beat market
expectations, helped by strength in its British unit TSB.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Mark Potter)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.